An academic paper published last week by Dr Evan
Anderson and others raises an important issue. Currently at least 38 vaccines
are in clinical trials. Another dozen will soon enter the trial phase. All of
them will be tried on adults. Not a single vaccine has plans to run trials on
children.
In the past, many vaccines were designed for children:
measles, polio and tetanus. In April 1954, the polio vaccine was tried on 1.8
million children in the USA. By 1964, polio was eradicated from that country. Childhood
measles vaccines prevented 12.7 million deaths worldwide between 2000 and 2008.
Vaccines for adults do not get an automatic approval for
children. Children are not small adults. Their smaller airways make them more
vulnerable to low levels of inflammation. The vaccine dose for adults and
children also varies. Based on the weight of the patient, medicines can have
varying impact. As a rule, children will be given a smaller dose of medicine than
an adult. Vaccines work differently. The job of a vaccine is to educate the
immune cells so they can recognize a virus or bacteria later. Children get a
smaller dose of hepatitis A and hepatitis B, but a bigger dose of diphtheria and
pertussis than adults. From the latter two vaccines, adults are more likely to
experience side effects.
*****
Trials on children take a long time. Children are not
a homogenous group. A vaccine that is safe and effective on adults will be
first tried on teenagers. In steps, it will move after many months to the age
group 3-8. Finally, it will be tried on the youngest, below 3 years of age. The
process has different protocols, different approvals, and the parents have to
give an informed consent.
True, Covid-19 is not known to be dangerous for
children. As per the CDC data, out of the 190,000 deaths in the USA, only 121
were under the age of 21. Children are considered a low risk group, and are low
on the priority list of the vaccine developers.
*****
India is demographically a young country. 41% of its
population, 574 million are under 18 years of age. Vaccines are likely to be
available for Indian adults by end 2021 in the best case scenario. If the
trials on children were to start after that, we may be waiting for a pediatric
vaccine till 2023.
Yes, the 574 million Indian children are not a high
risk group. Still, all of them are currently locked up in their homes, the
majority unable to attend schools and colleges. Will this continue till the
pediatric vaccine is available?
*****
Children may not succumb to covid-19, but they can transmit the virus. In the absence
of a pediatric vaccine, they can continue to spread the disease to
non-vaccinated adults. USA is already debating whether the government can or
should mandate a vaccine for school attending children.
In my research, I could find three vaccines with some
plans for children. The Oxford plans include a trial on an age group 5-12, to
be completed by August 2021. Later this month, China’s Sinovac Biotech will try CoronaVac on 552 Chinese children aged between
3-17. Russia says it may start a trial on children after nine months.
*****
Dr Anderson’s concern is valid. He wants the developers
to start the trials for children now, so they could start safe school life in
autumn 2021. Children’s going to school is pivotal to the world coming out of
the pandemic.
Ravi
We do need vaccine for children to avoid more waves of corona virus.
ReplyDeleteThe other big question is whether people will have to pay for the vaccine - it is even being discussed in the UK.
ReplyDelete